Ceftriaxone Standard Dosing
For adults with normal renal and hepatic function, ceftriaxone is dosed at 1-2 grams once daily or in divided doses every 12 hours, with a maximum of 4 grams per day; for children, the standard dose is 50-75 mg/kg/day (max 2 grams) for most infections, and 100 mg/kg/day (max 4 grams) for meningitis. 1
Adult Dosing
The FDA-approved dosing for adults is straightforward 1:
- Standard infections: 1-2 grams IV/IM once daily (or divided every 12 hours)
- Maximum daily dose: 4 grams
- Infusion time: 30 minutes for IV administration
- No renal adjustment needed: Ceftriaxone is unique among cephalosporins in that dosing remains unchanged even with renal impairment, as it has dual biliary and renal excretion
Specific Adult Indications
- Uncomplicated gonorrhea: 250 mg IM single dose 1
- Surgical prophylaxis: 1 gram IV single dose, given 0.5-2 hours before surgery 1
- Complicated intra-abdominal infections: 1-2 grams every 12-24 hours 2
Important caveat: While no renal adjustment is typically required, patients with both severe renal and hepatic dysfunction should not exceed 2 grams daily and require close monitoring 1.
Pediatric Dosing
Pediatric dosing is weight-based with clear age-specific considerations 1:
Standard Pediatric Infections
- Skin/soft tissue infections: 50-75 mg/kg once daily (max 2 grams)
- Serious infections (non-meningitis): 50-75 mg/kg divided every 12 hours (max 2 grams daily)
- Acute otitis media: 50 mg/kg IM single dose (max 1 gram)
Meningitis Dosing
- Initial loading dose: 100 mg/kg (max 4 grams)
- Maintenance: 100 mg/kg/day once daily or divided every 12 hours (max 4 grams daily)
- Duration: 7-14 days typically 1
Recent pharmacokinetic data supports once-daily dosing (100 mg/kg) over twice-daily (50 mg/kg) for meningitis, as it achieves better CSF penetration and earlier target attainment (88% vs 53% probability at 24 hours for MIC 1 mg/L) 3.
Critical Neonatal Considerations
Neonates require special attention 1:
- Infusion time: 60 minutes (not 30) to reduce bilirubin encephalopathy risk
- Contraindications:
- Premature neonates (absolute contraindication)
- Any neonate ≤28 days receiving IV calcium-containing solutions
- Hyperbilirubinemic neonates
- Dosing in neonates when appropriate: Half-life is prolonged (19 hours vs 6-8 hours in adults), requiring dose reduction by up to 5-fold in the first week of life 4
Pharmacokinetic Principles
Ceftriaxone has unique properties that enable convenient dosing 1:
- Half-life: 5.8-8.7 hours in healthy adults, allowing once-daily dosing
- Protein binding: 85-95% (concentration-dependent)
- Excretion: 33-67% unchanged in urine, remainder in bile
- No accumulation concern: 15-36% accumulation with repeated dosing is clinically insignificant
Key advantage: The long half-life and high protein binding create sustained free drug concentrations above MIC for susceptible organisms throughout a 24-hour interval 5.
Target Attainment Considerations
Recent pharmacodynamic studies reveal important nuances 5, 6, 7:
- 2 grams once daily is adequate for pathogens with MIC ≤2 mg/L in non-ICU patients
- Higher doses or twice-daily dosing may be needed for:
- MIC ≥4 mg/L
- Augmented renal clearance (eGFR >130 mL/min/1.73m²)
- Critically ill patients
For patients with preserved renal function (eGFR >60 mL/min/1.73m²), consider 1 gram every 12 hours rather than 2 grams once daily to maintain adequate drug exposure 7.
Common Pitfalls
Calcium co-administration: Never mix with calcium-containing solutions; can precipitate and cause fatal outcomes, especially in neonates 1
Gallbladder pseudolithiasis: Appears as sludge on ultrasound, more common in children, reversible upon discontinuation 1
Prothrombin time monitoring: Required in patients with hepatic disease, malnutrition, or on vitamin K antagonists 1
Duration misconception: Continue for at least 2 days after symptom resolution; Streptococcus pyogenes requires minimum 10 days 1